Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
18th October 2023
Fibromyalgia: Insights and Perspectives from the Patient and Practitioner
This podcast series explores fibromyalgia from the patient and practitioner perspectives, featuring personal insights and the use of non-pharmacological approaches.
1
Mins
18th October 2023
Positive Impact of Prenatal Iron Supplements
Iron supplementation during pregnancy has been shown to successfully reduce maternal anaemia. However, access is not universal. Read more about he direct dispensation of iron supplements during follow-ups
Non-opioid pain medication wins FDA approval
FDA approved a new non-opioid medication for patients with post-operative pain who are being treated in hospital. Read more now.
Investigating the reality of rare disease research
Discover the reality behind the rare disease research with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer
1
Mins
17th October 2023
Graft-Versus-Host Disease: Safety of Prophylactic Donor Lymphocyte Infusion
A research team conducted a retrospective study evaluating the efficacy and safety of prophylactic DLI for GVHD prophylaxis after PTCy-based haplo-HCT in paediatric patients with high-risk myeloid neoplasms.
Pharma in Ireland
The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.
1
Mins
16th October 2023
Increased Risk for Oesophageal Cancer After Anti-Reflux Surgery
Despite anti-reflux surgery being recommended for patients with Barrett’s oesophagus in order to decrease the risk of later developing oesophageal adenocarcinoma, recent research suggests that it may be no more effective than anti-reflux medication.
1
Mins
16th October 2023
Alcohol Does Not Affect Virologic Response in Hepatitis C Virus
Recent research has shown that alcohol use during the early stages of direct-acting antiviral treatment was not linked to reduced odds for achieving sustained virologic response (SVR) in patients with chronic HCV infection.
3
Mins
13th October 2023
UEG 2023 Interview: Patrizia Burra
Regarding my decision to undertake my studies in the field of gastroenterology, a prominent role was certainly played by my mentor, Remo…
1
Mins
13th October 2023
Waitlist Outcomes Improved by Living Donor Liver Transplantation
Waitlist outcomes are improved by living donor liver transplantation for high-risk patients with cirrhosis, according to a recent study. This study aimed to assess the impact of access to LDLT in waitlisted patients at highest risk of dropout.
←
1
2
3
…
142
143
144
145
146
147
148
…
898
899
900
→